15
Participants
Start Date
July 31, 2010
Primary Completion Date
November 30, 2012
Study Completion Date
December 31, 2015
Recombinant Vaccinia GM-CSF; RAC VAC GM-CSF (JX-594)
Intravenous Dose Range: 1x10\^6 pfu/kg, 1x10\^7 pfu/kg, 3x10\^7 pfu/kg Up to 4 intravenous infusions administered over 60 minutes every 2 weeks.
Samsung Medical Center, Seoul
Lead Sponsor
Samsung Medical Center
OTHER
Jennerex Biotherapeutics
INDUSTRY